Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The diet‐derived short chain fatty acid propionate improves beta‐cell function in humans and stimulates insulin secretion from human islets in vitro
Attilio Pingitore, Edward S. Chambers, T. G. HILL, et al.
Diabetes Obesity and Metabolism (2016) Vol. 19, Iss. 2, pp. 257-265
Open Access | Times Cited: 239

Showing 1-25 of 239 citing articles:

Introduction to the human gut microbiota
Elizabeth Thursby, Nathalie Juge
Biochemical Journal (2017) Vol. 474, Iss. 11, pp. 1823-1836
Open Access | Times Cited: 2788
Causal relationships among the gut microbiome, short-chain fatty acids and metabolic diseases
Serena Sanna, Natalie R. van Zuydam, Anubha Mahajan, et al.
Nature Genetics (2019) Vol. 51, Iss. 4, pp. 600-605
Open Access | Times Cited: 1191
Gut microbial metabolites in obesity, NAFLD and T2DM
Emanuel E. Canfora, Ruth C. R. Meex, Koen Venema, et al.
Nature Reviews Endocrinology (2019) Vol. 15, Iss. 5, pp. 261-273
Open Access | Times Cited: 1101
Short chain fatty acids in human gut and metabolic health
Ellen E. Blaak, Emanuel E. Canfora, Stephan Theis, et al.
Beneficial Microbes (2020) Vol. 11, Iss. 5, pp. 411-455
Open Access | Times Cited: 704
Role of Gut Microbiota-Generated Short-Chain Fatty Acids in Metabolic and Cardiovascular Health
Edward S. Chambers, Tom Preston, Gary Frost, et al.
Current Nutrition Reports (2018) Vol. 7, Iss. 4, pp. 198-206
Open Access | Times Cited: 556
The role of short-chain fatty acids in the interplay between gut microbiota and diet in cardio-metabolic health
Ana Nogal, Ana M. Valdes, Cristina Menni
Gut Microbes (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 499
The role of short-chain fatty acids in intestinal barrier function, inflammation, oxidative stress, and colonic carcinogenesis
Pinyi Liu, Yanbing Wang, Ge Yang, et al.
Pharmacological Research (2021) Vol. 165, pp. 105420-105420
Closed Access | Times Cited: 438
Are Short Chain Fatty Acids in Gut Microbiota Defensive Players for Inflammation and Atherosclerosis?
Hideo Ohira, Wao Tsutsui, Yoshio Fujioka
Journal of Atherosclerosis and Thrombosis (2017) Vol. 24, Iss. 7, pp. 660-672
Open Access | Times Cited: 422
Dietary Fibre Modulates the Gut Microbiota
Peter Cronin, Susan A. Joyce, Paul W. O’Toole, et al.
Nutrients (2021) Vol. 13, Iss. 5, pp. 1655-1655
Open Access | Times Cited: 420
Short-Chain Fatty-Acid-Producing Bacteria: Key Components of the Human Gut Microbiota
William G. Fusco, Manuel Bernabeu, Marco Cintoni, et al.
Nutrients (2023) Vol. 15, Iss. 9, pp. 2211-2211
Open Access | Times Cited: 380
Microbiota and metabolic diseases
Alessia Pascale, Nicoletta Marchesi, Cristina Marelli, et al.
Endocrine (2018) Vol. 61, Iss. 3, pp. 357-371
Closed Access | Times Cited: 373
The gut microbiome as a target for prevention and treatment of hyperglycaemia in type 2 diabetes: from current human evidence to future possibilities
Louise Brunkwall, Marju Orho‐Melander
Diabetologia (2017) Vol. 60, Iss. 6, pp. 943-951
Open Access | Times Cited: 319
Dietary supplementation with inulin-propionate ester or inulin improves insulin sensitivity in adults with overweight and obesity with distinct effects on the gut microbiota, plasma metabolome and systemic inflammatory responses: a randomised cross-over trial
Edward S. Chambers, Claire Byrne, Douglas J. Morrison, et al.
Gut (2019) Vol. 68, Iss. 8, pp. 1430-1438
Open Access | Times Cited: 316
Functions of Gut Microbiota Metabolites, Current Status and Future Perspectives
Juan Liu, Yuzhu Tan, Hao Cheng, et al.
Aging and Disease (2022) Vol. 13, Iss. 4, pp. 1106-1106
Open Access | Times Cited: 244
Therapeutic potential of ectopic olfactory and taste receptors
Sung‐Joon Lee, Inge Depoortere, Hanns Hatt
Nature Reviews Drug Discovery (2018) Vol. 18, Iss. 2, pp. 116-138
Closed Access | Times Cited: 236
Microbiota in anorexia nervosa: The triangle between bacterial species, metabolites and psychological tests
Francesca Borgo, Alessandra Riva, Alberto Benetti, et al.
PLoS ONE (2017) Vol. 12, Iss. 6, pp. e0179739-e0179739
Open Access | Times Cited: 220
Polysaccharide from Plantago asiatica L. attenuates hyperglycemia, hyperlipidemia and affects colon microbiota in type 2 diabetic rats
Qixing Nie, Jielun Hu, He Gao, et al.
Food Hydrocolloids (2017) Vol. 86, pp. 34-42
Closed Access | Times Cited: 179
Gut microbiota influence in type 2 diabetes mellitus (T2DM)
Andrew Cunningham, Jeffrey W. Stephens, Dean Harris
Gut Pathogens (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 169
The Role of the Gut Microbiota in the Relationship Between Diet and Human Health
Bryce K. Perler, Elliot S. Friedman, Gary D. Wu
Annual Review of Physiology (2022) Vol. 85, Iss. 1, pp. 449-468
Open Access | Times Cited: 168
Metformin-induced changes of the gut microbiota in healthy young men: results of a non-blinded, one-armed intervention study
T. Bryrup, Cæcilie W. Thomsen, Timo Kern, et al.
Diabetologia (2019) Vol. 62, Iss. 6, pp. 1024-1035
Open Access | Times Cited: 167
Dynamic balancing of intestinal short-chain fatty acids: The crucial role of bacterial metabolism
Youqiang Xu, Yang Zhu, Xiuting Li, et al.
Trends in Food Science & Technology (2020) Vol. 100, pp. 118-130
Closed Access | Times Cited: 164
Role of Gut Microbiota on Onset and Progression of Microvascular Complications of Type 2 Diabetes (T2DM)
Daniela Maria Tănase, Evelina Maria Gosav, Ecaterina Neculae, et al.
Nutrients (2020) Vol. 12, Iss. 12, pp. 3719-3719
Open Access | Times Cited: 153
Dietary fiber‐derived short‐chain fatty acids: A potential therapeutic target to alleviate obesity‐related nonalcoholic fatty liver disease
Shumin Zhang, Jingwen Zhao, Fei Xie, et al.
Obesity Reviews (2021) Vol. 22, Iss. 11
Closed Access | Times Cited: 143
Eicosapentaenoic and docosahexaenoic acids attenuate hyperglycemia through the microbiome-gut-organs axis in db/db mice
Pan Zhuang, Haoyu Li, Jia Wang, et al.
Microbiome (2021) Vol. 9, Iss. 1
Open Access | Times Cited: 117
The effects of dietary fibers from rice bran and wheat bran on gut microbiota: An overview
Wanzi Yao, Yufeng Gong, Chunsheng Li, et al.
Food Chemistry X (2022) Vol. 13, pp. 100252-100252
Open Access | Times Cited: 76
Page 1 - Next Page

Scroll to top